V. Marconi

R. Schinazi, V. Marconi, E. Aklillu, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy

B. Agan, Kirk A Easley, M. Paiardini, 2020, PloS one.

Antiretroviral reduction: is it time to rethink the unthinkable?

B. Taiwo, V. Marconi, J. Colasanti, 2014, AIDS.

Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy

R. Shafer, R. Paredes, J. Montaner, 2014, AIDS.

Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy

Jessie K. Edwards, Richard D Moore, S. Cole, 2021, AIDS.

CrAssphage as a Novel Tool to Detect Human Fecal Contamination on Environmental Surfaces and Hands

T. Ng, Anna Montmayeur, J. Vinjé, 2020, Emerging infectious diseases.

Higher Prevalence of Frailty Among a Sample of HIV-Infected Middle-aged and Older Chinese Adults Is Associated With Neurocognitive Impairment and Depressive Symptoms

Yan V. Sun, Xing Liu, V. Marconi, 2017, The Journal of infectious diseases.

Crosstalk between Host Genome and Metabolome among People with HIV in South Africa

Yan V. Sun, D. Kuritzkes, V. Marconi, 2022, Metabolites.

Microvascular Disease, Peripheral Artery Disease and Amputation.

Marc P. Bonaca, J. Beckman, S. Damrauer, 2019, Circulation.

Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV + , treatment-naïve U . S . veterans

Yan V. Sun, D. Rimland, V. Marconi, 2022 .

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Cameron R. Wolfe, A. Amin, M. Proschan, 2020, The New England journal of medicine.

Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era.

V. Marconi, W. Armstrong, C. Kelley, 2019, AIDS research and human retroviruses.

Bilirubin Is Inversely Associated With Cardiovascular Disease Among HIV‐Positive and HIV‐Negative Individuals in VACS (Veterans Aging Cohort Study)

J. Beckman, A. Justice, V. Marconi, 2018, Journal of the American Heart Association.

Community‐Acquired Pneumonia and Risk of Cardiovascular Events in People Living With HIV

Kathleen M. Akgün, M. Budoff, A. Justice, 2020, Journal of the American Heart Association.

Are HIV-positive persons progressing faster after diagnosis over the epidemic?

L. Eberly, B. Agan, A. Weintrob, 2010, Journal of acquired immune deficiency syndromes.

Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2017, Journal of acquired immune deficiency syndromes.

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.

B. Walker, D. Kuritzkes, E. Losina, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Second-Line Antiretroviral Therapy: Long-Term Outcomes in South Africa

J. Nachega, D. Kuritzkes, V. Marconi, 2012, Journal of acquired immune deficiency syndromes.

Effectiveness of an Interactive, Highly Tailored “Video Doctor” Intervention to Suppress Viral Load and Retain Patients With HIV in Clinical Care: A Randomized Clinical Trial

Alexa M Ortiz, Brittany A. Zulkiewicz, G. Marks, 2022, Journal of acquired immune deficiency syndromes.

Weight gain stopping/switch rules for antiretroviral clinical trials.

M. Siedner, E. Delaporte, S. Khoo, 2021, AIDS.

The Role of Behavioral Health in Optimizing Care for Complex Patients in the Primary Care Setting

V. Marconi, N. Kaslow, Benjamin F. Miller, 2016, Journal of General Internal Medicine.

Response: Association of Duffy Antigen Genotypes with HIV-AIDS Susceptibility

R. Weiss, V. Marconi, M. Dolan, 2009 .

Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2

A. Mehta, A. Ganesan, P. Tebas, 2022, Open forum infectious diseases.

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

C. del Rio, L. Lam, C. Libertin, 2021, The Lancet Respiratory Medicine.

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

Michael R. Wierzbicki, Tom M. Conrad, Cameron R. Wolfe, 2021, The Lancet Respiratory Medicine.

Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al

R. Schinazi, V. Marconi, M. Farley, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outcomes after virologic failure of first-line ART in South Africa

D. Kuritzkes, E. Losina, V. Marconi, 2010, AIDS.

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals

Helen M. Chun, K. H. Hullsiek, B. Agan, 2010, AIDS.

C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial

A. Badley, V. Marconi, F. Cerasoli, 2022, Thorax.

The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.

M. Landrum, R. Weiss, V. Marconi, 2009, Blood.

Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy

C. Fichtenbaum, P. Sax, S. Gianella, 2018, Journal of acquired immune deficiency syndromes.

The Impacts of Residential Location on the Risk of HIV Virologic Failure Among ART Users in Durban, South Africa

Michael R. Kramer, V. Marconi, K. Wall, 2019, AIDS and Behavior.

The role of CD101-expressing CD4 T cells in HIV/SIV pathogenesis and persistence

E. Boritz, J. Brenchley, G. Silvestri, 2022, PLoS pathogens.

Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, Georgia

V. Marconi, I. Ofotokun, W. Armstrong, 2020, AIDS.

Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: case report and review of the literature.

D. Hospenthal, V. Marconi, F. Marty, 2010, Medical mycology.

Reply to Cerda-Contreras, et al.

R. Schinazi, V. Marconi, M. Farley, 2020, Clinical Infectious Diseases.

Response to Correspondence: Baricitinib as Treatment of COVID-19 Friend or Foe of the Pancreas? Cerda-Contreras et.al.

R. Schinazi, V. Marconi, M. Farley, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Gut-derived bacterial toxins impair memory CD4+ T cell mitochondrial function in HIV-1 infection

M. Ghannoum, R. Sékaly, M. Retuerto, 2022, The Journal of clinical investigation.

Comparing effectiveness of first‐line antiretroviral therapy between peri‐urban and rural clinics in KwaZulu‐Natal, South Africa

D. Kuritzkes, V. Marconi, Jonathan Z. Li, 2021, HIV medicine.

Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials.

M. Siedner, E. Delaporte, S. Khoo, 2022, AIDS.

Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015.

Richard D Moore, Jennifer S. Lee, Jeffrey N. Martin, 2020, The Journal of infectious diseases.

Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007.

D. Metzgar, J. Tate, L. Anderson, 2009, The Journal of infectious diseases.

Baricitinib plus Standard of Care for Hospitalised Adults with COVID-19 on Invasive Mechanical Ventilation or Extracorporeal Membrane Oxygenation: Results of a Randomized, Placebo-Controlled Trial.

E. Ely, S. de Bono, V. Marconi, 2021, medRxiv.

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021

Anthony Z. Matolek, S. Schrag, M. McMorrow, 2021, MMWR. Morbidity and mortality weekly report.

A packaged intervention to improve viral load monitoring within a deeply rural health district of South Africa

D. Kuritzkes, K. Castro, V. Marconi, 2020, BMC Infectious Diseases.

Increasing Age at HIV Seroconversion From 18 to 40 Years Is Associated With Favorable Virologic and Immunologic Responses to HAART

M. Roediger, B. Agan, A. Weintrob, 2008, Journal of acquired immune deficiency syndromes.

1648. Incidence of Norovirus and Rotavirus From Multisite Active Surveillance in Veteran’s Affairs Hospitals, December 2016–February 2018: Results From the SUPERNOVA Network

J. Vinjé, U. Parashar, V. Marconi, 2018, Open Forum Infectious Diseases.

Incidence, etiology, and severity of acute gastroenteritis among prospectively enrolled patients in 4 Veterans Affairs hospitals and outpatient centers, 2016-18.

J. Vinjé, U. Parashar, V. Marconi, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Retention in HIV care depends on patients’ perceptions of the clinic experience

D. Rimland, V. Marconi, M. Hennink, 2017, AIDS care.

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults with HIV.

M. Lederman, C. Flexner, C. del Rio, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Non-Communicable Diseases: Yet Another Challenge for HIV Treatment and Care in Sub-Saharan Africa.

B. Agan, V. Marconi, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of pre-existing drug resistance on risk of virological failure in South Africa.

R. Paredes, D. Kuritzkes, Katherine Rodriguez, 2021, The Journal of antimicrobial chemotherapy.

Coccidioidal meningitis after liver transplantation in a nonendemic region: a case report.

R. Chung, V. Marconi, J. Fishman, 2006, Transplantation.

Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment

M. Perkins, A. Justice, D. Rimland, 2018, AIDS and behavior.

Correction to: Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment

M. Perkins, A. Justice, D. Rimland, 2018, AIDS and Behavior.

The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the United States

A. Collier, J. Simoni, V. Marconi, 2021, AIDS Research and Therapy.

Validating Self-Reported Unhealthy Alcohol Use With Phosphatidylethanol (PEth) Among Patients With HIV.

J. Dziura, A. Justice, V. Marconi, 2020, Alcoholism, clinical and experimental research.

Understanding HIV Risk Behavior from a Sociocultural Perspective.

V. Marconi, Claudia E. Ordóñez, C. Ordóñez, 2012, Journal of AIDS & clinical research.

Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection

R. Schinazi, V. Marconi, P. Hsue, 2020, Journal of the American Heart Association.

The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates

M. Siedner, V. Marconi, G. George, 2017, HIV clinical trials.

Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019

R. Schinazi, V. Marconi, M. Farley, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Concurrent use of traditional medicine and ART: Perspectives of patients, providers and traditional healers in Durban, South Africa

V. Marconi, M. Hennink, J. Hampton, 2015, Global public health.

Diagnosis and Management of HIV-Associated Pulmonary Diseases in a Ryan White-Funded Primary Care Setting.

V. Marconi, B. Staitieh, S. Auld, 2021, AIDS patient care and STDs.

Progestogen-Only Injectable Hormonal Contraceptive Use Should be Considered in Analysis of Studies Addressing the Loss of Bone Mineral Density in HIV-Positive Women

L. Eberly, B. Agan, A. Weintrob, 2010 .

Role of CCL3L1-CCR5 Genotypes in the Epidemic Spread of HIV-1 and Evaluation of Vaccine Efficacy

B. Agan, V. Marconi, M. Dolan, 2008, PloS one.

HIV-1 Disease-Influencing Effects Associated with ZNRD1, HCP5 and HLA-C Alleles Are Attributable Mainly to Either HLA-A10 or HLA-B*57 Alleles

B. Agan, M. Landrum, V. Marconi, 2008, PloS one.

FIB‐4 stage of liver fibrosis predicts incident heart failure among HIV‐infected and uninfected patients

M. Budoff, A. Justice, D. Rimland, 2017, Hepatology.

Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial

C. Fichtenbaum, P. Sax, E. Acosta, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa

M. Siedner, V. Marconi, G. George, 2021, Annals of Internal Medicine.

HIV treatment adherence, drug resistance, virologic failure: Evolving concepts

J. Nachega, R. Gross, E. Mills, 2022 .

The Effect of Human Immunodeficiency Virus on Hepatitis B Virus Serologic Status in Co-Infected Adults

B. Agan, A. Weintrob, A. Ganesan, 2010, PloS one.

Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patients

R. Schinazi, E. Acosta, V. Marconi, 2015, AIDS.

3 Social Determinants of HIV Health Care : A Tale of Two Cities

V. Marconi, C. Rio, R. Doshi, 2018 .

Social Determinants of HIV Health Care: A Tale of Two Cities

V. Marconi, C. Rio, R. Doshi, 2011 .

Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes.

R. Paredes, S. Lockman, V. Marconi, 2013, The Journal of infectious diseases.

CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals

D. Richman, S. Little, S. Frost, 2008, Nature Medicine.

Global epidemiology of drug resistance after failure of WHO recommended fi rst-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

Huldrych F. Günthard, Tulio de Oliveira, Lynn Morris, 2019 .

Early Postseroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1–Postive Subjects Receiving Antiretroviral Therapy

Michael A. Polis, B. Agan, G. Wortmann, 2011, Journal of acquired immune deficiency syndromes.

Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study

B. Agan, A. Weintrob, A. Ganesan, 2010, AIDS research and therapy.

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

Huldrych F. Günthard, Dominique Goedhals, Susan P. Holmes, 2017, EBioMedicine.

Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa

D. Kuritzkes, V. Marconi, R. Gandhi, 2012, PloS one.

Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study

M. Lederman, C. Flexner, C. del Rio, 2021, Journal of clinical pharmacology.

High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen

D. Kuritzkes, V. Marconi, M. Gordon, 2012, AIDS.

Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study

Heng Tang, H. Xing, Y. Ruan, 2017, BMJ Open.

Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations

Kirk A Easley, E. Acosta, V. Marconi, 2014, Journal of clinical pharmacology.

Commentary: Malaria and HIV transmission: old meets new in a deadly partnership or an opportunity for healthcare synergism?

V. Marconi, 2011, International journal of epidemiology.

Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.

Edward Wright, Stuart Neil, B. Agan, 2008, Cell host & microbe.

Increasing Rates of Obesity among HIV-Infected Persons during the HIV Epidemic

L. Eberly, M. Roediger, B. Agan, 2010, PloS one.

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study

K. H. Hullsiek, B. Agan, A. Weintrob, 2009, AIDS.

Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV-positive, treatment-naive U.S. veterans

Yan V. Sun, A. Justice, D. Rimland, 2017, AIDS.

Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors

J. Routy, R. Schinazi, R. Sékaly, 2017, PLoS pathogens.

The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention.

J. Nachega, V. Marconi, M. Jordan, 2011, Infectious disorders drug targets.

Pathways to Retention in HIV Care Among U.S. Veterans.

V. Marconi, M. Hennink, B. Kaiser, 2018, AIDS research and human retroviruses.

DNA methylation biomarker selected by an ensemble machine learning approach predicts mortality risk in an HIV-positive veteran population

D. Hancock, A. Justice, V. Marconi, 2019, Epigenetics.

Biological ageing with HIV infection: evaluating the geroscience hypothesis

Yan V. Sun, V. Marconi, M. Montano, 2022, The Lancet. Healthy longevity.

A complex system of chemokines may hold the key to optimal CD4+ T-cell recovery after antiretroviral therapy

Yan V. Sun, V. Marconi, Yan V. Sun, 2020, EBioMedicine.

Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.

B. Agan, A. Weintrob, A. Ganesan, 2009, The Journal of infectious diseases.

The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.

Elizabeth L. Beam, Sean G. Kaufman, Jennifer A. Schuck, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine

Jeffrey N. Martin, R. Paredes, D. Kuritzkes, 2008, Journal of Virology.

Oral microbiome in HIV-associated periodontitis

R. Paredes, T. Read, V. Marconi, 2017, Medicine.

Risk of Incident Diabetes Mellitus, Weight Gain, and their Relationships with Integrase Inhibitor-based Initial Antiretroviral Therapy Among Persons with HIV in the US and Canada.

Richard D Moore, T. Sterling, M. Gill, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A nurse-led intervention to improve management of virological failure in public sector HIV clinics in Durban, South Africa: A pre- and post-implementation evaluation.

M. Siedner, V. Marconi, H. Sunpath, 2021, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study

R. Shafer, P. Kaleebu, D. Pillay, 2016, The Lancet. Infectious diseases.

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.

D. Katzenstein, N. Ford, R. Shafer, 2013, The Journal of infectious diseases.

M. Siedner, S. Ng, V. Marconi, 2023, Value in health regional issues.

CTLA‐4+PD‐1− Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy‐Suppressed, SIV‐Infected Rhesus Macaques

R. Balderas, R. Sékaly, Kirk A Easley, 2017, Immunity.

A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS

Brigitte C. Madrian, David I. Laibson, J. Beshears, 2017, AIDS.

Risk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia

C. del Rio, V. Marconi, W. Armstrong, 2015, AIDS care.

Who’s slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first‐line HIV treatment in Uganda and South Africa

M. Siedner, V. Marconi, G. George, 2021, HIV medicine.

Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing

R. Paredes, D. Kuritzkes, V. Marconi, 2016, AIDS.

Management of Virologic Failure and Human Immunodeficiency Virus Drug Resistance.

M. Siedner, V. Marconi, S. Mccluskey, 2019, Infectious disease clinics of North America.

Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models

M. Siedner, V. Marconi, G. George, 2019, Journal of medical economics.

Low CD4/CD8 ratio predicts cancer risk among adults with HIV

Richard D Moore, J. Sun, T. Sterling, 2021 .

Epigenome-wide epidemiologic studies of human immunodeficiency virus infection, treatment, and disease progression

Yan V. Sun, M. Gwinn, V. Marconi, 2022, Clinical epigenetics.

Depression as a Risk Factor for Incident Ischemic Stroke Among HIV‐Positive Veterans in the Veterans Aging Cohort Study

S. Crystal, V. Marconi, M. Freiberg, 2021, Journal of the American Heart Association.

Telehealth Exercise Intervention in Older Adults With HIV: Protocol of a Multisite Randomized Trial.

J. Sorkin, A. Ryan, V. Marconi, 2021, The Journal of the Association of Nurses in AIDS Care : JANAC.

Positive Health Check evaluation: A type 1 hybrid design randomized trial to decrease HIV viral loads in patients seen in HIV primary care

Alexa M Ortiz, Brittany A. Zulkiewicz, V. Marconi, 2020, Contemporary clinical trials.

Viral suppression among persons in HIV care in the United States during 2009-2013: sampling bias in Medical Monitoring Project surveillance estimates.

Richard D Moore, P. Sullivan, C. Rentsch, 2019, Annals of epidemiology.

Updates of Lifetime Costs of Care and Quality-of-Life Estimates for HIV-Infected Persons in the United States: Late Versus Early Diagnosis and Entry Into Care

J. Brooks, D. Rimland, V. Marconi, 2013, Journal of acquired immune deficiency syndromes.

White Blood Count, Albumin, and BMI Enhance VACS Index Prognostic Model, but Nadir CD4 and CD8 Metrics Do Not

A. Justice, D. Rimland, V. Marconi, 2017, Open Forum Infectious Diseases.

Baseline, Time-Updated, and Cumulative HIV Care Metrics for Predicting Acute Myocardial Infarction and All-Cause Mortality.

M. Budoff, D. Leaf, C. Rentsch, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

IL-10 driven memory T cell survival and Tfh differentiation promote HIV persistence

D. Hazuda, N. Krogan, R. Balderas, 2021, bioRxiv.

Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members

B. Walker, D. Rimland, V. Marconi, 2019, eLife.

Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial

V. Marconi, A. Fekadu, Y. Woldeamanuel, 2020, Trials.

The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the U.S. - applying lessons from high-burden settings.

V. Marconi, W. Armstrong, M. Nguyen, 2020, AIDS.

Differences in expression of gut-homing receptors on CD4+ T cells in black and white HIV-negative men who have sex with men

P. Sullivan, M. Mulligan, V. Marconi, 2016, AIDS.

Machine learning selected smoking-associated DNA methylation signatures that predict HIV prognosis and mortality

Hongyu Zhao, Gang Peng, John H. Krystal, 2018, Clinical Epigenetics.

Impact of Availability of Telehealth Programs on Documented HIV Viral Suppression: A Cluster-Randomized Program Evaluation in the Veterans Health Administration.

Michael P. Jones, M. Vaughan-Sarrazin, V. Marconi, 2019, Open forum infectious diseases.

HIV care using differentiated service delivery during the COVID‐19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs

C. Rentsch, Roozbeh Yousefzadeh, A. Justice, 2021, Journal of the International AIDS Society.

Patient Experiences with Telemedicine for HIV Care during the first COVID-19 Wave in Atlanta, Georgia.

V. Marconi, Sarita Shah, K. Galaviz, 2021, AIDS research and human retroviruses.

Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE ε4/ε4 genotype accelerates HIV disease progression

Jeff E. Mold, Brian K. Agan, Vincent C. Marconi, 2008, Proceedings of the National Academy of Sciences.

HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer

A. Justice, M. Gerschenson, R. Tracy, 2017, Journal of acquired immune deficiency syndromes.

Progress in achieving long-term HIV remission

M. Paiardini, V. Marconi, M. Pino, 2018, Current opinion in HIV and AIDS.

Occupational exposure to blood and other bodily fluids at a military hospital in Iraq.

C. Murray, N. Conger, V. Marconi, 2009, The Journal of trauma.

Associations of inflammation-related proteome with demographic and clinical characteristics of people with HIV in South Africa

D. Kuritzkes, V. Marconi, Q. Hui, 2022, medRxiv.

Novel Predictors of Poor Retention Following a Down-Referral from a Hospital-Based Antiretroviral Therapy Program in South Africa.

C. del Rio, V. Marconi, Brent A Johnson, 2016, AIDS research and human retroviruses.

Proceedings of the 13th annual conference of INEBRIA

I. White, K. Kraemer, S. Shortreed, 2016, Addiction Science & Clinical Practice.

V. Marconi, M. Rodriguez‐Barradas, M. Holodniy, 2020, JMIR public health and surveillance.

Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support

Patrick R. Alba, Kathleen M. Akgün, C. Rentsch, 2021, European Respiratory Journal.

Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial

J. Dziura, L. Fiellin, A. Justice, 2020, Addiction Science & Clinical Practice.

FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C.

M. Budoff, A. Justice, D. Rimland, 2020, Progress in cardiovascular diseases.

Hospital-acquired device-associated infections at a deployed military hospital in Iraq.

C. Murray, V. Marconi, Erica N Johnson, 2008, The Journal of trauma.

Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART

J. Brenchley, K. Delman, R. Sékaly, 2021, PLoS pathogens.

Efficacy and safety of baricitinib in patients with COVID-19 infection: Results from the randomised, double-blind, placebo-controlled, parallel-group COV-BARRIER phase 3 trial

Brenda J. Crowe, D. Adams, E. Ely, 2021 .

Baricitinib plus Standard of Care for Hospitalized Adults with COVID-19

Brenda J. Crowe, S. de Bono, V. Marconi, 2021, medRxiv.

Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America

Richard D Moore, P. Tien, M. Horberg, 2022, Lancet Regional Health. Americas.

Septic Arthritis Involving Kluyvera Species After Anterior Cruciate Ligament Reconstruction: A Case Report

V. Marconi, J. Okulicz, V. Prakash, 2011 .

Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first‐line therapy in South Africa: a case–control cohort study

D. Kuritzkes, V. Marconi, I. Ofotokun, 2021, Journal of the International AIDS Society.

Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort Study.

M. Budoff, S. Gottlieb, V. Marconi, 2021, PloS one.

Insomnia as an Independent Predictor of Incident Cardiovascular Disease in HIV: Data From the Veterans Aging Cohort Study

M. Budoff, S. Gottlieb, V. Marconi, 2019, Journal of acquired immune deficiency syndromes.

Mortality Among Persons Entering HIV Care Compared With the General U.S. Population

Jessie K. Edwards, Richard D Moore, S. Cole, 2021, Annals of Internal Medicine.

Epigenetic Associations with Estimated Glomerular Filtration Rate (eGFR) among Men with HIV Infection.

Yan V. Sun, M. Gwinn, A. Justice, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort

L. Eberly, B. Agan, A. Weintrob, 2011, AIDS research and therapy.

The continuum of HIV care in a Veterans' Affairs clinic.

D. Rimland, V. Marconi, Jed P. Mangal, 2014, AIDS research and human retroviruses.

Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS

Michael A. Polis, B. Agan, A. Ganesan, 2011, PloS one.

Virologic Response Differences Between African Americans and European Americans Initiating Highly Active Antiretroviral Therapy With Equal Access to Care

B. Agan, A. Weintrob, A. Ganesan, 2009, Journal of acquired immune deficiency syndromes.

2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings.

B. Gazzard, R. Kaiser, B. Larder, 2021, The Journal of antimicrobial chemotherapy.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings

Dechao Wang, Shanmugam Saravanan, John Baxter, 2018, The Journal of antimicrobial chemotherapy.

An Innovative Physical Therapy Intervention for Chronic Pain Management and Opioid Reduction Among People Living with HIV

C. del Rio, V. Marconi, S. Pullen, 2020, BioResearch open access.

CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.

B. Agan, A. Weintrob, A. Ganesan, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Religious Beliefs and Depression: Psychosocial Factors Affecting HIV Treatment Outcomes in South Africa.

P. Sullivan, V. Marconi, Baohua Wu, 2017, New voices in psychology.

The combination of pill count and self-reported adherence is a strong predictor of first-line ART failure for adults in South Africa.

Brent A. Johnson, J. Nachega, V. Marconi, 2014, Current HIV research.

Correction: Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa

D. Kuritzkes, V. Marconi, R. Gandhi, 2013, PLoS ONE.

ADHERENCE AS MAJOR DETERMINANT OF HIV TREATMENT OUTCOMES : CLINICAL AND PUBLIC HEALTH

J. Nachega, R. Gross, E. Mills, 2022 .

Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure

M. Siedner, V. Marconi, M. Gandhi, 2023, AIDS.

Spontaneous virologic suppression in HIV controllers is independent of delayed-type hypersensitivity test responsiveness

G. Wortmann, M. Landrum, V. Marconi, 2012, AIDS Research and Therapy.

Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals

Kristof Theys, Pieter Libin, Pieter J. K. Libin, 2017, Viruses.

Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations.

R. Paredes, D. Kuritzkes, V. Marconi, 2007, Journal of virological methods.

Associations between chronic pain, analgesic use and physical therapy among adults living with HIV in Atlanta, Georgia: a retrospective cohort study

C. del Rio, V. Marconi, S. Pullen, 2019, AIDS care.

Early initiation of corticosteroids in patients hospitalized with COVID-19 not requiring intensive respiratory support: cohort study

Patrick R. Alba, C. Rentsch, A. Justice, 2021, medRxiv.

Adapting the Surveillance Platform for Enteric and Respiratory Infectious Organisms at United States Veterans Affairs Medical Centers (SUPERNOVA) for COVID-19 Among Hospitalized Adults: Surveillance Protocol

V. Marconi, E. Meites, M. Rodriguez‐Barradas, 2021, Frontiers in Public Health.

Differential expression of chemokine receptors on monocytes in TB and HIV S

U. Sack, Y. Belay, V. Marconi, 2023, Heliyon.

Reply to Pomara et al. and Valcour et al.: Age and the APOE ε4/ε4 genotype in HIV-1-associated dementia

R. Mahley, B. Agan, J. McCune, 2008, Proceedings of the National Academy of Sciences.

Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV

S. Crystal, A. Justice, V. Marconi, 2021, AIDS and Behavior.

DNA Methylation Markers of Type 2 Diabetes Mellitus Among Male Veterans With or Without Human Immunodeficiency Virus Infection.

M. Gwinn, A. Justice, V. Marconi, 2019, The Journal of infectious diseases.

Food Insecurity Is Associated With Low Tenofovir Diphosphate in Dried Blood Spots in South African Persons With HIV

D. Kuritzkes, V. Marconi, P. Anderson, 2023, Open forum infectious diseases.

Cognitively Based Compassion Training for HIV Immune Nonresponders—An Attention-Placebo Randomized Controlled Trial

R. Schinazi, V. Marconi, T. Pace, 2021, Journal of acquired immune deficiency syndromes.

The fight to end tuberculosis must not be forgotten in the COVID-19 outbreak

V. Marconi, A. Fekadu, Y. Woldeamanuel, 2020, Nature Network Boston.

Viral Dynamics and In Vivo Fitness of HIV-1 in the Presence and Absence of Enfuvirtide

Sebastian Bonhoeffer, Rebecca Hoh, Roger Paredes, 2008, Journal of acquired immune deficiency syndromes.

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

Domenico Di Carlo, P. A. Bester, R. Shafer, 2022 .

Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study

B. Agan, A. Weintrob, A. Ganesan, 2010, AIDS Research and Therapy.

Urban-Rural Disparities in Treatment Outcomes Among Recurrent TB Cases in Zambia

K. Dobbin, V. Marconi, S. Mutembo, 2019 .

Clinical effectiveness of integrase strand transfer inhibitor-based antiretroviral regimens among adults with human immunodeficiency virus: a collaboration of cohort studies in the United States and Canada.

Jessie K. Edwards, Richard D Moore, S. Cole, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Physical Therapy for Chronic Pain Mitigation and Opioid Use Reduction Among People Living with HIV in Atlanta, GA: A Descriptive Case Series.

Samantha L. Zimmerman, C. del Rio, V. Marconi, 2020, AIDS research and human retroviruses.

Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007.

Scott Wegner, Vincent Marconi, L. Eberly, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Open Access Research

B. Agan, A. Weintrob, A. Ganesan, 2022 .

Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations

Kirk A Easley, E. Acosta, V. Marconi, 2014, Journal of clinical pharmacology.

PDL1 expression on monocytes is associated with plasma cytokines in Tuberculosis and HIV

U. Sack, V. Marconi, K. Bauer, 2021, PloS one.

The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.

M. Landrum, R. Weiss, V. Marconi, 2009, Blood.